Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Table 2

Positive rates of autoantibodies against Ezrin for ESCC.

Group		Positive (%)	value
ESCC	149	41 (27.5%)	<0.0001
Early-stage ESCC (0 + I)	18	5 (27.8%)	<0.0001
Advanced ESCC (II + III + IV)	131	36 (27.5%)	<0.0001
Normal controls	98	4 (4.1%)

ESCC: esophageal squamous cell carcinoma. value is relative to normal controls. Statistical significance was determined using the test.